Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
Book a demo Book a demo
☰
CPT Code

CPT code 33249 – Transvenous ICD system insertion


Code Definition

33249 is the CPT code for insertion or replacement of a permanent implantable defibrillator system, with transvenous lead(s), single or dual chamber. The code covers the pulse generator and the transvenous lead or leads placed in the same session.

Three problems account for most denials on this code. They are a missing or undated LVEF study, an ICD-10 pairing that fails Medicare NCD 20.4, and a skipped prior authorization.

Section
10004-69990 Surgery
Subsection
33016-37799 Cardiovascular system
Code range
33202-33273 Pacemaker or Implantable Defibrillator
Billable
No
Code also known as
ICD implant, implantable defibrillator placement, cardiac defibrillator insertion, CRT-D implant (when LV lead included)
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key takeaways

Key takeaways

CPT code 33249 covers a new or replacement transvenous ICD system. Subcutaneous systems take 33270, and a generator-only swap takes 33262, 33263 or 33264.

Primary-prevention coverage under NCD 20.4 needs a documented LVEF of 35% or below, plus a recorded shared decision-making encounter.

33249 carries 23.89 total RVUs under the CY2026 Medicare Physician Fee Schedule, the same in facility and non-facility settings.

Missing LVEF documentation and ICD-10 pairing mismatches are the two leading denial causes. A pre-submission checklist prevents both.

Pabau’s claims management software supports structured billing workflows for high-complexity cardiac codes, including pre-authorization tracking and claim status visibility.

CPT code 33249: Official descriptor and clinical scope

CPT code 33249 reports insertion or replacement of a permanent transvenous implantable defibrillator system, single or dual chamber. The generator and the transvenous lead or leads are both paid under this one code.

The American Medical Association’s CPT code set gives 33249 one official descriptor. It reads: Insertion or replacement of permanent implantable defibrillator system, with transvenous lead(s), single or dual chamber.

Pocket creation and intraoperative device programming are included in the code and cannot be billed separately. Defibrillation threshold testing performed at implant is the exception, and it is reported with CPT 93641.

  • Included in 33249: pulse generator implantation, transvenous lead insertion (right ventricular and/or right atrial), pocket creation, intraoperative sensing and impedance measurement, device programming
  • Not included: left ventricular lead placement (bill CPT 33225 as an add-on), the electrophysiologic evaluation at implant (CPT 93641), remote monitoring setup
  • Not covered by 33249: subcutaneous ICD systems (33270), generator-only replacement (33262, 33263 or 33264), lead extraction

What the procedure involves: Clinical overview

Understanding the surgical steps matters because operative note documentation must map directly to what CPT code 33249 covers. An electrophysiologist performs the procedure under fluoroscopic guidance, typically under conscious sedation or general anesthesia.

  1. Venous access: subclavian or cephalic vein accessed via cutdown or percutaneous puncture
  2. Lead placement: right ventricular shocking coil lead advanced to the RV apex; right atrial lead placed if dual-chamber system
  3. Pocket formation: prepectoral or subpectoral pocket created for the pulse generator
  4. Generator connection and testing: leads connected, impedance and sensing thresholds measured, defibrillation threshold (DFT) testing performed
  5. Closure: pocket irrigated and closed; fluoroscopy images documented in the operative report

The operative note must reflect each of these steps. A note that simply states “ICD implanted without complication” lacks the procedural detail payers expect to confirm that all bundled components were performed.

Medicare coverage criteria for CPT 33249 (NCD 20.4)

Medicare coverage for CPT code 33249 is governed by National Coverage Determination 20.4, administered by the Centers for Medicare and Medicaid Services. Claims that do not satisfy NCD 20.4 are denied for medical necessity regardless of diagnosis code accuracy. The criteria differ by clinical indication.

Indication LVEF Threshold Additional NCD Requirements
Primary prevention, ischemic cardiomyopathy 35% or below (30% or below for NYHA Class I) Prior MI at least 40 days before implant. NYHA Class I, II or III. Guideline-directed medical therapy (GDMT) for at least 3 months. Documented shared decision-making encounter.
Primary prevention, non-ischemic cardiomyopathy 35% or below NYHA Class II or III. GDMT for at least 3 months. Cardiomyopathy not expected to improve with revascularization. Documented shared decision-making encounter.
Secondary prevention (prior VT/VF or cardiac arrest) No LVEF floor required Documented sustained VT/VF not due to a transient reversible cause. Prior cardiac arrest survived, with the arrhythmia documented.
Familial or inherited conditions (e.g., LQTS, Brugada syndrome, HCM) Not applicable Documented high-risk genetic arrhythmia syndrome. An electrophysiologist’s assessment in the record is best practice, not an NCD requirement.

The LVEF measurement must be dated. CMS expects the echo or nuclear study to have been performed within a reasonable timeframe before the procedure. A value greater than 35% or an undated study will trigger a medical necessity denial.

NCD 20.4 also requires a shared decision-making encounter before a primary-prevention implant, using an evidence-based decision aid. Record it as its own dated note rather than a line inside the consultation letter.

ICD-10 diagnosis codes that support medical necessity

Every CPT code 33249 claim requires at least one ICD-10-CM diagnosis code that supports the clinical indication. Payers cross-reference the diagnosis against NCD 20.4 criteria automatically. Mismatches cause immediate rejection.

ICD-10-CM Code Description Indication
I25.10 Atherosclerotic heart disease of native coronary artery without angina pectoris Primary prevention, ischemic
I42.0 Dilated cardiomyopathy Primary prevention, non-ischemic
I49.01 Ventricular fibrillation Secondary prevention
I47.29 Other ventricular tachycardia Secondary prevention
Z82.49 Family history of ischemic heart disease and other diseases of the circulatory system Familial/inherited risk (secondary diagnosis)

I47.2 has not been billable since 1 October 2022, so a claim carrying it will reject on the code itself. Use I47.29 for documented ventricular tachycardia, or I47.20 where the type is not specified.

Use the most specific available code. For an ischemic primary-prevention implant, I25.10 is the usual pairing, supported by the catheterization or imaging report. Do not use I42.9 when a documented etiology is in the record, because unspecified codes trigger additional documentation requests from Medicare Administrative Contractors.

The defibrillator family spans new implants, generator-only exchanges, subcutaneous systems and pacing devices. Selecting the wrong code among these is the most common technical billing error on these procedures.

Code Descriptor (short) Key differentiator from 33249
33249 Transvenous ICD, new or replacement system, single or dual chamber Primary code; covers the generator plus the transvenous lead or leads
33262 ICD pulse generator replacement, existing single lead Generator only; the lead already in place is left untouched
33263 ICD pulse generator replacement, existing dual leads Generator only, dual-lead system; 33264 covers a multiple-lead system
33270 Subcutaneous ICD, insertion with electrode No transvenous leads; S-ICD only, and the electrode alone is 33271
33208 Permanent pacemaker insertion, dual chamber Pacing only, no defibrillation capability; wrong code if an ICD was implanted

The most consequential distinction is 33249 against a generator-only exchange. If the surgeon removed the existing generator and reused the leads already in place, the correct code is 33262, 33263 or 33264. Which one depends on how many leads the system carries. Billing 33249 for that case claims lead work nobody performed.

One add-on code attaches to 33249, and one further code covers a separate service performed in the same session. Both depend on what the operative note actually records.

  • CPT 33225 (add-on): left ventricular lead placement for cardiac resynchronization therapy. Bill 33225 alongside 33249 when a CRT-D system is implanted and the LV lead is placed in the same session. It is never reported alone.
  • CPT 93641 (separate service): electrophysiologic evaluation of a single- or dual-chamber pacing cardioverter-defibrillator at the time of implant. Report it when defibrillation threshold or induction testing is performed and documented. Check current NCCI edits before filing, as bundling rules have changed in recent update cycles.

Fluoroscopic guidance is bundled into the implant and is not separately reportable, so 76000 does not belong on the claim. The ICD pulse generator and the leads are not billed on the physician claim either. The facility is paid for the device through its own claim, under the inpatient DRG or the outpatient OPPS rate.

Prior authorization requirements by payer

Medicare fee-for-service does not require prior authorization for CPT code 33249 as a standalone requirement. However, prior authorization is commonly required by Medicare Advantage plans, commercial insurers, and managed Medicaid programs. Skipping this step accounts for a disproportionate share of preventable denials.

  • BCBS plans (BCBSNC, BCBSMS, and most regional affiliates): Require PA for 33249. Submit clinical notes, LVEF documentation, and EP consultation. Allow 3-5 business days for standard PA; urgent cases generally require a peer-to-peer call within 24 hours.
  • Carelon Medical Benefits Management (Wellpoint): Requires PA for ICD implantation. Carelon manages cardiac procedures for multiple commercial payers; confirm which plans use Carelon as their utilization management vendor before submitting.
  • Novitas Solutions (MAC J-H and J-L): Does not require pre-procedure PA for original Medicare, but local coverage articles (LCAs) define documentation requirements that function similarly. Confirm current LCA requirements at the Novitas provider portal.
  • Medicare Advantage: Each plan sets its own PA policy. Some mirror original Medicare NCD 20.4; others impose additional clinical criteria. Always verify with the specific plan before scheduling an elective implant.

For emergency ICD implants, document the emergent nature in the record and submit retroactive authorization where required. Most payers accept retrospective review for life-threatening indications. Reviewing medical billing compliance standards for your payer mix keeps the authorization step from being skipped on urgent cases.

Documentation the payer expects in the record

Incomplete documentation is the root cause of most 33249 denials that survive the initial edit scrub. The medical record must contain all of the following before the claim is submitted. Pabau, the practice management platform we build, includes software for billing teams that holds a claim in the queue until every item is attached.

Pabau claims and billing dashboard showing the status of submitted claims
Pabau’s claims dashboard shows where each 33249 claim sits, so a case missing its LVEF date is caught before submission.
  • LVEF measurement with date: a dated echocardiogram or nuclear study carrying the interpreting physician’s name. Primary prevention cases need LVEF at or below 35%.
  • Clinical indication documentation: EP consultation note stating the indication (primary vs secondary prevention), NYHA class, and etiology of cardiomyopathy
  • Shared decision-making note: a dated record of the pre-implant discussion with the patient, using an evidence-based decision aid
  • GDMT confirmation: for primary prevention cases, documentation that the patient was on optimal guideline-directed medical therapy for at least 3 months before implant
  • Prior MI timing (ischemic etiology): catheterization report or clinical note establishing MI occurred at least 40 days before the procedure
  • Operative note: surgeon documentation of venous access, lead placement locations, sensing and impedance measurements, DFT testing results, and generator model/serial number
  • Device implant log: manufacturer implant card or device log confirming pulse generator and lead model numbers, lot numbers, and implant date
  • Prior authorization number: if PA was obtained, the authorization number must appear on the claim

Several of these items carry a deadline that predates the procedure, so the order they are gathered in matters as much as the list itself.

Timeline of CPT 33249 documentation deadlines: guideline-directed medical therapy at least 3 months before implant, prior myocardial infarction at least 40 days before, a dated LVEF study at 35% or below plus a shared decision-making encounter and prior authorization before the implant date, and the operative note and device implant log on the day of implant
Five of the seven requirements fall due before the patient reaches the lab, so a check at submission finds them too late. Source: Medicare NCD 20.4 and payer documentation rules.

Pro Tip

Run a pre-claim checklist against this list for every 33249 case before it leaves the billing queue. A single missing item is enough to trigger a medical necessity denial. The LVEF date and the GDMT documentation are the usual culprits, and the appeal then takes 60 to 90 days.

Medicare reimbursement rate for CPT 33249

Medicare reimbursement for CPT code 33249 is calculated from the Medicare Physician Fee Schedule (MPFS), which the Centers for Medicare and Medicaid Services updates annually. The CMS Physician Fee Schedule lookup tool provides current payment amounts by locality.

RVU Component CY2026 RVUs Notes
Work RVUs 14.55 Physician cognitive and technical effort
Practice expense RVUs 5.91 Identical in facility and non-facility settings
Malpractice RVUs 3.43 PLI component
Total RVUs 23.89 Multiplied by the annual conversion factor for dollar payment

RVU values change with each annual MPFS rule. Use the FastRVU lookup tool or the CMS fee schedule download to confirm current values, then apply your geographic practice cost index (GPCI) adjustment. The device itself is not inside this professional fee. The facility is paid for it on its own claim.

The electronic remittance advice (ERA/835) returned after payment posts will show the allowed amount, any contractual adjustment, and the patient responsibility. Reconciling ERAs against expected MPFS rates for 33249 is a straightforward way to catch underpayments.

Common denial reasons and how to avoid them

Most denials on CPT code 33249 fall into five categories. Each is avoidable with pre-claim checks rather than post-denial appeals. Understanding denial management workflows reduces the 60 to 90-day lag that unresolved cardiac code denials typically create.

  • Medical necessity not met (NCD 20.4): the most common denial type. Caused by an LVEF above 35% in the record, or by a primary prevention implant without documented GDMT for 3 months. Prevention: confirm all NCD criteria are documented before the procedure date is entered in the billing system.
  • Missing or undated LVEF: a separate denial from the above. Even when LVEF is below 35%, a study without a date or without the interpreting physician’s signature fails payer edit checks. Prevention: require a dated, signed echo report as a claim hold release condition.
  • Incorrect ICD-10 pairing: using an unspecified cardiomyopathy code (I42.9) when a specific etiology is documented. A rhythm code alone will not support a primary prevention implant either. Prevention: run an AAPC code crosswalk and confirm the diagnosis-procedure pairing maps to a covered NCD indication.
  • Prior authorization not obtained: commercial and Medicare Advantage plans that require PA deny 33249 outright. The claim carries no authorization number for them to match. Prevention: build PA verification into the surgical scheduling workflow, not the billing workflow.
  • NCCI bundling edit triggered: billing 33249 alongside a generator-only code such as 33262, or alongside 33270 for a subcutaneous system. These describe mutually exclusive procedures and NCCI edits reject the pair. Prevention: review denial reason codes on returned claims to catch the mismatch early and correct the code selection at source.

Building a clean claim for 33249 means all five issues are resolved before submission. Post-denial correction on a cardiac device implant averages more rework than almost any other inpatient procedure code.

Modifier usage on the implant claim

Modifier selection decides whether 33249 is paid at full value, at a reduced rate, or split between two surgeons. On a code this large, the wrong modifier costs either revenue or an audit.

Modifier When to use Documentation required
-22 Increased procedural services; procedure substantially more complex than typical Operative note must describe the specific complexity factors (severe adhesions, anomalous anatomy, prolonged DFT testing); payer typically requires a cover letter
-52 Reduced services; procedure intentionally less than described (e.g., lead only partially placed, procedure terminated early) Operative note must clearly state what was not performed and why; reimbursement reduced proportionally
-62 Two surgeons; both an electrophysiologist and a cardiac surgeon perform distinct components Both surgeons submit 33249 with -62; each receives 62.5% of the fee schedule amount; each operative note must reflect that surgeon’s distinct contribution
-80 Assistant surgeon; a second physician provides surgical assistance Confirm 33249 is on Medicare’s assistant-at-surgery allowed list before billing; not all cardiac device codes permit -80
-58 Staged or related procedure during the postoperative period Use when a planned second-stage procedure (e.g., lead revision) occurs within the global period of the initial 33249 implant

Pro Tip

Never append modifier -22 without a supporting cover letter. Payers that accept -22 on the claim form without documentation will pay initially, then audit and recoup. Document the complexity in the operative note at the time of surgery, not retrospectively.

How Pabau keeps 33249 claims clean before they are filed

In most cardiology practices the evidence for an NCD 20.4 claim is scattered. The echo report sits in the imaging system and the GDMT history in the medication list. The authorization number lives in a spreadsheet, and the implant log in a paper folder.

Pabau holds all of it against the appointment the implant was booked under. Uploaded reports, consent notes, authorization numbers and device details attach to the patient record, so the coder opens one screen instead of four. A pre-submission checklist then keeps the claim in the queue until the dated LVEF value is attached.

Fewer claims leave the practice short of one dated document. Denials that would have taken 60 to 90 days to appeal never get raised in the first place.

Streamline your cardiac billing workflow

Pabau gives cardiology and electrophysiology teams a structured workflow for high-complexity claims. Pre-submission checklists, real-time claim status, and integrated prior authorization tracking keep 33249 and related cardiac codes moving through the revenue cycle without manual follow-up.

Pabau claims management dashboard

Conclusion

CPT code 33249 carries substantial reimbursement and equally substantial documentation requirements. The two most preventable failure modes are undated LVEF studies and missed prior authorizations on commercial plans. A structured pre-claim workflow catches both before the claim is filed.

Decide where in your own workflow each deadline in the timeline above gets checked. A claim held at the scheduling desk costs a phone call, while the same claim held at the clearinghouse costs a quarter of revenue.

Pabau brings pre-authorization tracking, claim status and ERA reconciliation into one platform, which is where accurate medical billing starts for a cardiology team. To see how Pabau handles a 33249 claim end to end, book a demo.

Continue your research

Continue your research

Need to understand how claims move through a clearinghouse? Medical claims clearinghouse overview explains the submission and adjudication process from file validation through ERA posting.

Want to track down a denial’s root cause quickly? Claim.MD clearinghouse guide covers how Pabau’s US clearinghouse partner handles real-time eligibility, claim status, and CARC denial codes.

Looking to reduce claim errors across your revenue cycle? Revenue cycle management explained walks through the end-to-end RCM process and where cardiology billing teams typically lose revenue.

Frequently asked questions

What does CPT code 33249 cover?

CPT code 33249 covers insertion or replacement of a permanent transvenous implantable cardioverter-defibrillator (ICD) system, single or dual chamber. The pulse generator and all transvenous leads are included, along with pocket creation and intraoperative programming. Defibrillation threshold testing at implant is the exception, and it is reported separately with CPT 93641.

What is the Medicare reimbursement rate for CPT 33249?

The Medicare physician fee for CPT 33249 is based on 23.89 total RVUs under the CY2026 Physician Fee Schedule. That figure is multiplied by the annual conversion factor and adjusted for your locality. Use the CMS Physician Fee Schedule lookup for the current amount. The device is not inside this professional fee, because the facility is paid for it on its own claim.

What is the difference between CPT 33249 and CPT 33270?

CPT 33249 covers transvenous ICD systems, where the leads run through a vein into the heart chambers. CPT 33270 covers the subcutaneous ICD, whose electrode sits under the skin and never enters the vasculature. They are not interchangeable and cannot be billed together on the same claim.

Can CPT 33249 be billed with CPT 33225?

Yes. CPT 33225, which covers left ventricular lead placement for cardiac resynchronization therapy, is a designated add-on code to CPT 33249. When a CRT-D system is implanted in a single session and an LV lead is placed, bill both 33249 and 33225 together. CPT 33225 cannot be reported as a standalone code.

Which ICD-10 codes pair with this procedure?

The required ICD-10-CM diagnosis codes depend on the clinical indication. Common pairings include I25.10 for ischemic primary prevention, I42.0 for dilated cardiomyopathy, I49.01 for ventricular fibrillation, and I47.29 for other ventricular tachycardia. I47.2 was split on 1 October 2022 and is no longer billable. The selected code must map to a covered NCD 20.4 indication or the claim will be denied for medical necessity.

What are the most common denial reasons for CPT 33249?

The most common denials are NCD 20.4 medical necessity not met and a missing or undated LVEF study. An incorrect ICD-10 pairing and a missing prior authorization follow. NCCI bundling edits are the fifth, triggered by billing 33249 with a mutually exclusive code such as 33262 or 33270.

Does CPT 33249 require prior authorization?

Prior authorization is not required by original Medicare fee-for-service, but it is commonly required by Medicare Advantage plans, BCBS affiliates, and Carelon-managed commercial plans. Verify PA requirements with the specific payer before scheduling an elective implant. For emergent cases, document the emergent indication and submit retroactive authorization as the payer’s policy allows.

×